Lactoferrin: A Critical Mediator of Both Host Immune Response and Antimicrobial Activity in Response to Streptococcal Infections.
Jacky LuJamisha FrancisRyan S DosterKathryn P HaleyKelly M CraftRebecca E MooreSchuyler A ChambersDavid M AronoffKevin OsteenSteven M DamoShannon ManningSteven D TownsendJennifer A GaddyPublished in: ACS infectious diseases (2020)
Streptococcal species are Gram-positive bacteria responsible for a variety of disease outcomes including pneumonia, meningitis, endocarditis, erysipelas, necrotizing fasciitis, periodontitis, skin and soft tissue infections, chorioamnionitis, premature rupture of membranes, preterm birth, and neonatal sepsis. In response to streptococcal infections, the host innate immune system deploys a repertoire of antimicrobial and immune modulating molecules. One important molecule that is produced in response to streptococcal infections is lactoferrin. Lactoferrin has antimicrobial properties including the ability to bind iron with high affinity and sequester this important nutrient from an invading pathogen. Additionally, lactoferrin has the capacity to alter the host inflammatory response and contribute to disease outcome. This Review presents the most recent published work that studies the interaction between the host innate immune protein lactoferrin and the invading pathogen, Streptococcus.
Keyphrases
- immune response
- preterm birth
- recombinant human
- soft tissue
- inflammatory response
- candida albicans
- innate immune
- staphylococcus aureus
- intensive care unit
- acute kidney injury
- signaling pathway
- type diabetes
- low birth weight
- dendritic cells
- adipose tissue
- escherichia coli
- gram negative
- systematic review
- randomized controlled trial
- metabolic syndrome
- lps induced
- pseudomonas aeruginosa
- binding protein